Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AMGEN INCAMGN · Entity 2832 | SVP, Global Govt Affairs | May 03, 2012 | May 07, 2012 |
| Arcus Biosciences, Inc.RCUS · Entity 4104 | Director | June 06, 2019 | June 10, 2019 |
| INFINITY PHARMACEUTICALS, INC.INFI · Entity 109802 | Director | June 16, 2022 | June 16, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AMGEN INC
Report date May 03, 2012 · Filed May 07, 2012
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 37,210 |
Reported balance
After 2012-05-03 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2012-05-03 · Exercise / conversion · Acquired 1,598 · Balance 37,210 |
| Common StockSEC Table I · non-derivative | Direct | 60,612 |
Reported balance
After 2012-05-03 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2012-05-03 · Exercise / conversion · Acquired 23,402 · Balance 60,612 |
| Common StockSEC Table I · non-derivative | Direct | 70,612 |
Reported balance
After 2012-05-03 transaction · row 3
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 3 · 2012-05-03 · Exercise / conversion · Acquired 10,000 · Balance 70,612 |
| Common StockSEC Table I · non-derivative | Direct | 80,612 |
Reported balance
After 2012-05-03 transaction · row 4
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 4 · 2012-05-03 · Exercise / conversion · Acquired 10,000 · Balance 80,612 |
| Common StockSEC Table I · non-derivative | Direct | 90,612 |
Reported balance
After 2012-05-03 transaction · row 5
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 5 · 2012-05-03 · Exercise / conversion · Acquired 10,000 · Balance 90,612 |
| Common StockSEC Table I · non-derivative | Direct | 35,612 |
Reported balance
After 2012-05-03 transaction · row 6
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 6 · 2012-05-03 · Sale · Disposed 55,000 · Balance 35,612 F1: The price reported is an average price. The prices ranged from $70.545 to $70.77 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC staff, the issuer or a security holder of the issuer. F2: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 1,425 RSUs which fully vest on 4/28/2013; 2,900 RSUs which vest in two equal annual installments of 1,450 each commencing 4/26/2013; 7,500 RSUs which vest in two equal installments of 2,475 each on 4/25/2013 and 4/25/2014 and one installment of 2,550 on 4/25/2015; and 3,350 RSUs which vest in three installments of 1,105, 1,106 and 1,139 on 4/27/2014, 4/27/2015 and 4/27/2016, respectively. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. |
| Iso (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $62.55 · Expires 2014-04-26 | Direct | 0 |
Reported balance
After 2012-05-03 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2012-05-03 · Exercise / conversion · Disposed 1,598 · Balance 0 |
| Nqso (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $62.55 · Expires 2014-04-26 | Direct | 0 |
Reported balance
After 2012-05-03 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2012-05-03 · Exercise / conversion · Disposed 23,402 · Balance 0 |
| Nqso (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $42.13 · Expires 2015-04-29 | Direct | 0 |
Reported balance
After 2012-05-03 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2012-05-03 · Exercise / conversion · Disposed 10,000 · Balance 0 |
| Nqso (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $50.44 · Expires 2016-04-28 | Direct | 10,000 |
Reported balance
After 2012-05-03 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2012-05-03 · Exercise / conversion · Disposed 10,000 · Balance 10,000 |
| Nqso (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $58.43 · Expires 2020-04-26 | Direct | 20,000 |
Reported balance
After 2012-05-03 transaction · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · 2012-05-03 · Exercise / conversion · Disposed 10,000 · Balance 20,000 |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported is an average price. The prices ranged from $70.545 to $70.77 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC staff, the issuer or a security holder of the issuer.
F2: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 1,425 RSUs which fully vest on 4/28/2013; 2,900 RSUs which vest in two equal annual installments of 1,450 each commencing 4/26/2013; 7,500 RSUs which vest in two equal installments of 2,475 each on 4/25/2013 and 4/25/2014 and one installment of 2,550 on 4/25/2015; and 3,350 RSUs which vest in three installments of 1,105, 1,106 and 1,139 on 4/27/2014, 4/27/2015 and 4/27/2016, respectively. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
Arcus Biosciences, Inc.
Report date June 06, 2019 · Filed June 10, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $7.99 · Expires 2029-06-05 | Direct | 35,000 |
Reported balance
After 2019-06-06 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2019-06-06 · Grant · Acquired 35,000 · Balance 35,000 F1: The option will vest in full on the earlier of (i) 12 months following the date of grant or (ii) the date of the next annual stockholder meeting following the grant. The option becomes fully vested and exercisable in the event the Company is subject to a change in control. |
Filing footnotes · ownership attribution and instrument terms
F1: The option will vest in full on the earlier of (i) 12 months following the date of grant or (ii) the date of the next annual stockholder meeting following the grant. The option becomes fully vested and exercisable in the event the Company is subject to a change in control.
INFINITY PHARMACEUTICALS, INC.
Report date June 16, 2022 · Filed June 16, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.68 · Expires 2032-06-16 | Direct | 45,000 |
Reported balance
After 2022-06-16 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2022-06-16 · Grant · Acquired 45,000 · Balance 45,000 F1: The option vests over a period of one year in equal quarterly installments beginning at the end of the first quarter after the date of grant, provided that the holder continues to serve as a director of the issuer. |
Filing footnotes · ownership attribution and instrument terms
F1: The option vests over a period of one year in equal quarterly installments beginning at the end of the first quarter after the date of grant, provided that the holder continues to serve as a director of the issuer.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 26, 2010 Filed Apr 28, 2010 19:47 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 5,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-10-012268 · form4.xml · nonDerivative · entry 1 BEIER DAVID W · CIK 0001187054 · SVP Global Govt & Corp Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,687 F1 · shares: The Restricted Stock Units (RSUs) were granted pursuant to the Company's 2009 Equity Incentive Plan and vest in four equal annual installments of 25% each commencing April 26, 2011. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F2 · balance_after: These shares include the following RSUs granted under the Company's equity plans: 25,000 RSUs which fully vest on 7/31/2010; 8,550 RSUs which vest in three equal annual installments of 2,850 each commencing 4/29/2010; 5,700 RSUs which vest in four equal annual installments of 1,425 each commencing 4/28/2010; and 5,800 RSUs which vest in four equal installments of 1,450 each commencing on 4/26/2011. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. Read SEC document |
| March 12, 2010 Filed Mar 16, 2010 17:33 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 1,603 | $57.49 | $92,156.47 |
DisclosureSEC source: 0001127602-10-008757 · form4.xml · nonDerivative · entry 2 BEIER DAVID W · CIK 0001187054 · SVP Global Govt & Corp Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,887 F1 · security: These shares include the following Restricted Stock Units (RSUs) granted under the Company's Amended and Restated 1991 Equity Incentive Plan: 25,000 RSUs which fully vest on 7/31/2010; 8,550 RSUs which vest in three equal annual installments of 2,850 each commencing 4/29/2010; and 5,700 RSUs which vest in four equal annual installments of 1,425 each commencing 4/29/2010. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis unless payment is otherwise deferred by the reporting person. Read SEC document |
| March 12, 2010 Filed Mar 16, 2010 17:33 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 4,740 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-10-008757 · form4.xml · nonDerivative · entry 1 BEIER DAVID W · CIK 0001187054 · SVP Global Govt & Corp Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,490 F1 · security: These shares include the following Restricted Stock Units (RSUs) granted under the Company's Amended and Restated 1991 Equity Incentive Plan: 25,000 RSUs which fully vest on 7/31/2010; 8,550 RSUs which vest in three equal annual installments of 2,850 each commencing 4/29/2010; and 5,700 RSUs which vest in four equal annual installments of 1,425 each commencing 4/29/2010. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis unless payment is otherwise deferred by the reporting person. Read SEC document |
| June 03, 2009 Filed Jun 5, 2009 17:00 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 6,884 | $50.43 | $347,140.16 |
DisclosureSEC source: 0001127602-09-013341 · form4.xml · nonDerivative · entry 1 BEIER DAVID W · CIK 0001187054 · SVP Global Govt & Corp Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,750 F1 · security: These shares include the following Restricted Stock Units (RSUs) granted under the Company's Amended and Restated 1991 Equity Incentive Plan: 25,000 RSUs which fully vests on 7/31/2010; 8,550 RSUs which vest in three equal annual installments of 2,850 each commencing 4/29/2010; and 5,700 RSUs which vests in four equal annual installments of 1,425 each commencing 4/29/2010. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis unless payment is otherwise deferred by the reporting person. F2 · price: The sale price is an average sale price with a low of $50.40 per share and a high of $50.47 per share. A detailed list of the number of shares sold and the sale price of each share is available upon request by the SEC staff, the issuer or a security holder of the issuer. Read SEC document |
| May 08, 2009 Filed May 8, 2009 21:00 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 2,435 | $47.63 | $115,979.05 |
DisclosureSEC source: 0001127602-09-011014 · form4.xml · nonDerivative · entry 2 BEIER DAVID W · CIK 0001187054 · SVP Global Govt & Corp Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,716 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's Amended and Restated 1991 Equity Incentive Plan: 25,000 RSUs which fully vests on 7/31/2010; 8,550 RSUs which vest in three equal annual installments of 2,850 each commencing 4/29/2010; and 5,700 RSUs which vests in four equal annual installments of 1,425 each commencing 4/29/2010. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis unless payment is otherwise deferred by the reporting person. Read SEC document |
| May 07, 2009 Filed May 8, 2009 21:00 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 7,387 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-09-011014 · form4.xml · nonDerivative · entry 1 BEIER DAVID W · CIK 0001187054 · SVP Global Govt & Corp Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,151 Read SEC document |
| April 29, 2009 Filed May 1, 2009 20:28 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 918 | $50.44 | $46,303.92 |
DisclosureSEC source: 0001127602-09-010289 · form4.xml · nonDerivative · entry 1 BEIER DAVID W · CIK 0001187054 · SVP Global Govt & Corp Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,764 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's Amended and Restated 1991 Equity Incentive Plan: 25,000 RSUs which fully vests on July 31, 2010; 8,550 RSUs which vest in three equal annual installments of 2,850 each commencing 4/29/2010; and 5,700 RSUs which vests in four equal annual installments of 1,425 each commencing 4/29/2010. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis unless payment is otherwise deferred by the reporting person. Read SEC document |
| April 28, 2009 Filed Apr 29, 2009 22:20 UTC | AMGEN INC AMGN · Entity 2832 | GrantNqso (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $50.44 | $0.00 |
DisclosureSEC source: 0001127602-09-009978 · form4.xml · derivative · entry 3 BEIER DAVID W · CIK 0001187054 · SVP Global Govt & Corp Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2016-04-28 F3 · derivative.exercise_date: These shares are exercisable in four equal annual installments of 25% each commencing 04/28/2010. Read SEC document |
| April 28, 2009 Filed Apr 29, 2009 22:20 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 5,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-09-009978 · form4.xml · nonDerivative · entry 1 BEIER DAVID W · CIK 0001187054 · SVP Global Govt & Corp Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,700 F1 · security: The Restricted Stock Units (RSUs) were granted pursuant to the Company's Amended and Restated 1991 Equity Incentive Plan (the "1991 Plan"). RSUs vest in four equal annual installments of 25% each commence April 28, 2010. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis unless payment is otherwise deferred by the reporting person. Read SEC document |
| October 23, 2008 Filed Oct 24, 2008 23:13 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 100 | $52.94 | $5,294.00 |
DisclosureSEC source: 0001181431-08-058293 · rrd221482.xml · nonDerivative · entry 7 BEIER DAVID W · CIK 0001187054 · SVP Global Govt & Corp Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,900 Read SEC document |
| October 23, 2008 Filed Oct 24, 2008 23:13 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 500 | $52.92 | $26,460.00 |
DisclosureSEC source: 0001181431-08-058293 · rrd221482.xml · nonDerivative · entry 6 BEIER DAVID W · CIK 0001187054 · SVP Global Govt & Corp Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Read SEC document |
| October 23, 2008 Filed Oct 24, 2008 23:13 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 1,000 | $52.91 | $52,910.00 |
DisclosureSEC source: 0001181431-08-058293 · rrd221482.xml · nonDerivative · entry 5 BEIER DAVID W · CIK 0001187054 · SVP Global Govt & Corp Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,500 Read SEC document |
| October 23, 2008 Filed Oct 24, 2008 23:13 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 100 | $52.85 | $5,285.00 |
DisclosureSEC source: 0001181431-08-058293 · rrd221482.xml · nonDerivative · entry 4 BEIER DAVID W · CIK 0001187054 · SVP Global Govt & Corp Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,500 Read SEC document |
| October 23, 2008 Filed Oct 24, 2008 23:13 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 500 | $52.83 | $26,415.00 |
DisclosureSEC source: 0001181431-08-058293 · rrd221482.xml · nonDerivative · entry 3 BEIER DAVID W · CIK 0001187054 · SVP Global Govt & Corp Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,600 Read SEC document |
| October 23, 2008 Filed Oct 24, 2008 23:13 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 300 | $52.84 | $15,852.00 |
DisclosureSEC source: 0001181431-08-058293 · rrd221482.xml · nonDerivative · entry 2 BEIER DAVID W · CIK 0001187054 · SVP Global Govt & Corp Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,100 Read SEC document |
| October 23, 2008 Filed Oct 24, 2008 23:13 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 420 | $52.86 | $22,201.20 |
DisclosureSEC source: 0001181431-08-058293 · rrd221482.xml · nonDerivative · entry 1 BEIER DAVID W · CIK 0001187054 · SVP Global Govt & Corp Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,400 Read SEC document |
| May 27, 2008 Filed May 28, 2008 22:51 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 9,000 | $43.01 | $387,099.00 |
DisclosureSEC source: 0001181431-08-035030 · rrd208587.xml · nonDerivative · entry 1 BEIER DAVID W · CIK 0001187054 · SVP Global Govt & Corp Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,820 Read SEC document |
| May 12, 2008 Filed May 14, 2008 21:16 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 4,557 | $41.86 | $190,756.02 |
DisclosureSEC source: 0001181431-08-031355 · rrd206649.xml · nonDerivative · entry 1 BEIER DAVID W · CIK 0001187054 · SVP Global Govt & Corp Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,820 Read SEC document |
| May 07, 2008 Filed May 9, 2008 21:29 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 14,153 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-08-030271 · rrd206052.xml · nonDerivative · entry 1 BEIER DAVID W · CIK 0001187054 · SVP Global Govt & Corp Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,377 Read SEC document |
| April 29, 2008 Filed May 1, 2008 00:05 UTC | AMGEN INC AMGN · Entity 2832 | GrantNQSO (Right to Buy) · Derivative | 40,000 | $42.13 Strike: $42.13 | $1,685,200.00 |
DisclosureSEC source: 0001181431-08-027700 · rrd204688.xml · derivative · entry 2 BEIER DAVID W · CIK 0001187054 · SVP Global Govt & Corp Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2015-04-29 F2 · derivative.exercise_date: This option is exercisable in four equal annual installments of 25% each commencing April 29, 2009. Read SEC document |
| April 29, 2008 Filed May 1, 2008 00:05 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 11,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-08-027700 · rrd204688.xml · nonDerivative · entry 1 BEIER DAVID W · CIK 0001187054 · SVP Global Govt & Corp Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,224 F1 · security: The Restricted Stock Units (RSUs) were granted pursuant to the Company's Amended and Restated 1991 Equity Incentive Plan. RSUs vest in four equal annual installments of 25% each commencing on April 29, 2009. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis unless payment is otherwise deferred by the executive officer. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.